These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 15517934)

  • 1. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
    Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
    Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.
    Nampoory MR; Johny KV; al-Hilali N; Seshadri MS; Kanagasabhapathy AS
    Nephrol Dial Transplant; 1996 Jan; 11(1):177-81. PubMed ID: 8649630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country.
    Otedo AE; Mc'Ligeyo SO; Okoth FA; Kayima JK
    S Afr Med J; 2003 May; 93(5):380-4. PubMed ID: 12830604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of long-term erythropoietin treatment on insulin, glucagon, pancreatic polypeptide, and gastrin secretion in haemodialysed patients.
    Kokot F; Nieszporek T; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
    Nephrol Dial Transplant; 1994; 9 Suppl 3():35-9. PubMed ID: 8072722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units.
    Oguchi H; Miyasaka M; Tokunaga S; Hora K; Ichikawa S; Ochi T; Yamada K; Nagasawa M; Kanno Y; Aizawa T
    Clin Nephrol; 1992 Jul; 38(1):36-43. PubMed ID: 1499167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of hepatitis C infection activity on oxidative stress markers and erythropoietin requirement in hemodialysis patients.
    Tutal E; Sezer S; Ibis A; Bilgic A; Ozdemir N; Aldemir D; Haberal M
    Transplant Proc; 2010 Jun; 42(5):1629-36. PubMed ID: 20620489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis B virus markers and anti-HCV antibodies in hemodialyzed patients].
    Illés M; Szontágh L; Gál G
    Orv Hetil; 1992 Jul; 133 Suppl 1():27-30. PubMed ID: 1630802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.
    Mederacke I; Meier M; Lüth JB; Schmidt-Gürtler H; Raupach R; Horn-Wichmann R; Wursthorn K; Potthoff A; Colucci G; Manns MP; Wedemeyer H; Tillmann HL
    Nephrol Dial Transplant; 2011 Aug; 26(8):2648-56. PubMed ID: 21273235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of parathormone level on the doses of human recombinant erythropoietin in haemodialysed patients].
    Zelichowski G; Olszowska A; Lubas A; Wańkowicz Z
    Pol Merkur Lekarski; 2002 Nov; 13(77):373-5. PubMed ID: 12621751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of long-term recombinant human erythropoietin (rHuEpo) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients.
    Kokot F; Wiecek A; Mesjasz J; Adamczak M; Spiechowicz U
    Nephrol Dial Transplant; 1998 May; 13(5):1200-5. PubMed ID: 9623554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of long-term human recombinant erythropoietin treatment on secretion of pancreatic polypeptide and gastrin in hemodialysed patients with chronic renal failure].
    Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
    Przegl Lek; 1995; 52(12):590-3. PubMed ID: 8834657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV and HCV infection in Japanese dental care workers.
    Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of anti-HCV in patients on long-term hemodialysis.
    Oguchi H; Terashima M; Tokunaga S; Kiyosawa K; Tanaka E; Furuta S; Kanno Y; Aizawa T; Nishioka K
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):313-7. PubMed ID: 2113144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
    Anandh U; Thomas PP; Shastry JC; Jacob CK
    J Assoc Physicians India; 2000 Nov; 48(11):1061-3. PubMed ID: 11310381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.